Related Experiment Video

Updated: Aug 16, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Activating p38 MAPK: new tricks for an old kinase

Paul R Mittelstadt1, Jesús M Salvador, Albert J Fornace

  • 1Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. mittelsp@mail.nih.gov

Cell Cycle (Georgetown, Tex.)
|August 17, 2005
PubMed

Insights

Mitogen-activated protein kinases (MAPKs) use a cascade for activation. However, T cell receptor signaling activates p38 MAPK through a novel pathway, offering new therapeutic targets.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Immunology

Background:

  • Mitogen-activated protein kinases (MAPKs) are crucial signaling molecules activated by extracellular stimuli.
  • MAPKs typically activate through a conserved "MAPK cascade" involving sequential phosphorylation events.
  • The canonical activation culminates in dual phosphorylation on a Thr-X-Tyr motif.

Purpose of the Study:

  • To investigate the noncanonical activation of p38 MAPK via the T cell antigen receptor (TCR).
  • To explore the structural and functional consequences of this alternative signaling pathway.
  • To identify potential new targets for tissue-specific pharmacological interventions.

Main Methods:

  • Analysis of p38 MAPK activation in response to TCR stimulation.
  • Investigation of phosphorylation events on noncanonical residues.
  • Structural and functional characterization of the alternative activation pathway.

Main Results:

  • TCR-mediated stimulation bypasses the canonical MAPK cascade.
  • p38 MAPK is activated by phosphorylation at Tyr-323, a noncanonical residue.
  • This alternative pathway leads to p38 substrate phosphorylation and potential therapeutic implications.

Conclusions:

  • A novel p38 MAPK activation pathway exists downstream of TCR signaling.
  • This pathway involves noncanonical phosphorylation at Tyr-323.
  • This discovery presents a potential target for developing specific p38 inhibitors.

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...